reason report
play defens secular stori recur rev high
initi coverag healthcar technolog space
includ electron health record
pharma-fac
name believ battleground year healthcar
landscap recess fear headlin risk
surround elect context view hcit bomb shelter
broader healthcar landscap major health tech
name exist cost save optim solut healthcar
think space rel shield regulatori risk potenti
upsid end market come modest pressur given
uncertain macro backdrop prefer name benefit secular
growth trend overshadow market volatil high level
revenu visibl potenti upward estim revis
closest consum see strongest near-term
demand top pick look
rel safeti recess
top pick expect rocki tape next two
earn season compani either cut discontinu guidanc
reflect headwind look
two sleep-easi name within coverag univers low risk
downsid potenti upsid estim
mere weather stormboth pure play secular
consumer-driven trend telehealth chronic condit manag
offer top quartil growth independ macro
worri elong recess bomb shelter
model reflect headwind
compani inform svb leerink llc research
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
june acknowledg return path recess
anyon guess mind look name core
solut high level recur revenu attract yield
view name place hide
elong recess given incumb role respect
market gpo ehr clearinghous support healthi
balanc sheet could augment total sharehold return
step back continu believ
multi-year thesi broad hsa adopt market perform
compani outlook due outsiz exposur macro factor
includ interest rate unemploy market pullback
model declin mid singl digit top line growth
year note deceler could come cost high
correct made includ insert ep estimate
front page financi grid sinc miss
also insert revenu estimate ep estimate
front page financi grid complet revenu ep
divvi public landscap subsector industri player
privat landscap look healthcar pain point
rank univers
someth everyon
new ipo creat competit dollar
garp transit underway ehr
expect continu
entranc
impact
virtual becom front mind
improv deliveri consum experi
chang come healthcar payment
data continu matter
ai nlp ml reduc costadmin first
cloud final bring secur risk
health valuat right multipl
histor valuat multipl analysi time seri
sector perform recess
healthcar remain larg grow dynam market
healthcar largest privat sector unit state center medicar
medicaid servic size market trillion annual spend comparison
put domest healthcar industri size global payment market
accord bcg domest defens spend nearli domest
bank spend taken stand-alone unit annual domest healthcar spend would
largest economi world germani
despit outsiz scale domest healthcar market growth continu acceler
seen figur rate healthcar spend project increas point
come decad shift compound-annual-growth-rate compound-annual-growth-rate
repres point premium growth driven cost inflat within system
age popul increas rate chronic diseas
final think import note unlik larg establish market healthcar
remain one dynam end market us creat opportun disrupt
innov attribut evolv popul dynam includ health age
demograph continu evolut regul tie shift polit backdrop
penetr suggest near- term opportun
despit domest healthcar industri high rel matur scale penetr
account industri repres approxim uss
annual spend impli signific invest opportun healthcar technolog
penetr progress line industri assum healthcar sole
reach cross-industri penetr averag impli increment near
term revenu opportun healthcar technolog player approxim doubl today
secular tailwind fuel outsiz growth across sector
core healthcar technolog pure play cost contain healthcar
take variou formsspend track tool proactiv popul engag tech enabl
manual processesal requir greater degre tech enabl data track
within healthcar system drive growth across sector project substanti runway
growth total healthcar wast us alon compris
annual healthcar expenditur repres nearli quarter total healthcar spend
battleground year regul healthcar technolog rel safe
potenti upsid regul
believ battleground year healthcar landscap given upcom
elect broad array risk rang lower reach chang healthcar regul
sweep legisl chang medicar
context view healthcar technolog bomb shelter broader healthcar
landscap given rel safeti regul major hcit name exist cost
save optim play within healthcar view space rel shield
regulatori risk potenti upsid increas complex beget greater push
elect creat sector rotat risk healthcar
although believ elect risk could benefici healthcar technolog weight vs
healthcar sector note upcom elect could caus generalist rotat
healthcar sector includ healthcar tech avoid headlin risk could weigh
valuat across board especi at-risk name medicar
disintermedi behemoth
seen heighten interest technolog servic even payment vendor
recent year look capit outsiz growth signific white space
sector expos healthcar tech vendor disintermedi risk view
less like well headlin risk invest
domest healthcar technolog sector tradit domin healthcare-
face vertic focus vendor due nuanc sell healthcar end market
addit believ healthcar industri inher complex regulatori risk
act de facto moat keep larger vendor meaning enter market note
prevent cross-sector healthcar technolog includ truven
merg phytel explori fitbit morgan amazon pillpack
premium valuat risk growth sector longer growth market
healthcar technolog sector enjoy premium valuat compar mani healthcar
vertic sector driven premium growth profil attract secular trend
howev name coverag univers trade ev/revenu basi
see downsid risk recess investor could flee rel safeti growth note
particular risk pre-profit name earn
justifi floor multipl total compani healthcar technolog coverag
univers posit earn posit free cash flow
price power sustain risk end market pressur
unlik vertic platform model tradit experi price compress low
mid-singl digit upon renew hcit univers uniqu tend command price
power histor allow health tech name enjoy premium valuat line
hand vertic tech compani command price power
 hcit sector matur healthcar end market pressur
price power dynam could revert put risk hcit valuat see higher potenti
risk vendor face upmarket larger institut usual first mover price
healthcar technolog sector healthcar hcit sector compris broad array
softwar servic solut sold healthcar end market histor meant
solut sold primarili payer provid recent expand
group shoulder larger portion healthcar cost burden includ employe
benefit manag pharma compani consum
healthcar technolog industri hold numer parallel vertic sector albeit
much earlier stage along matur curv busi model standpoint often
translat pair platform solut well profession servic long-term
revenu contract high renew rate anddepend mix servicesa high increment
margin howev total compani margin tend lag vertic sector given earli stage
natur sector mani player still work toward profit
divvi public landscap subsector
acknowledg healthcar technolog sector bit busi model grab bag
result segment public player respect end market methodolog group
player compar growth matur margin profil often determin
end market budget spend trend
divid industri four primari subsector electron health record name
sometim also refer clinic system player nich provider-fac
solut nich payer-fac solut nich pharma-fac solut
electron health record name ehr provid electron health record platform
relat software/servic provid includ revenu cycl manag practic
manag pm patient portal host solut often also refer clinic
system name electron medic record name publicli trade compani within group
nxgn/market perform
ehr among first public compani within healthcar technolog space
aggreg year public compani experi across group combin govern
subsidi meaning use era put subsector furthest along
matur curv within healthcar technolog closest vertic platform player
although subsector technic could group provider-fac vertic believ
prudent carv group reflect rel matur slower growth
provider-fac name encompass nich softwar servic solut sold
healthcar provid vertic includ hospit health system ambulatori practic
solut within subsector gener tend toward cost manag outsourc
effici play publicli trade compani within group includ
pinc/outperform /market perform vocera vcra/underperform
compar ehr nich provider-fac name tend enjoy higher top line growth
profil off-set lower margin function less matur busi profil
similar provider-fac name payer-fac name sell nich platform solut
primarili payer end market origin encompass sole larg payer aetna
unit etc govern contract payer-focus name begun expand
employe benefit manag vertic compani take greater share health insur
cost solut within subsector includ telehealth consum direct benefit payment
accuraci broader analyt play payer-focus name includ hqy/
lvgo/outperform tabula rasa trhc/outperform teladoc tdoc/outperform
among end market payer spend trend tend similar enterpris spend
forward-look view project nimbl budget
payer-fac name tend command fastest growth within coverag univers
pharma-fac name sell nich platform data solut life scienc industri
includ pharmaceut compani solut within subsector includ clinic
trial manag big data/ai solut streamlin process quality/regulatori solut
consult current veeva veev/market perform public name within pharma-
face space follow octob date acquisit medidata mdso dassault
similar payer life scienc compani tend forward-look approach
technolog invest allow pharma-fac player enjoy premium growth rate
healthcar technolog space
privat landscap look healthcar pain point
greater number player allow greater specif segment
greater number player within privat healthcar technolog landscap allow greater
specif segment well beyond end buyer len use public market
figur outlin segment group privat healthcar technolog
player pain point solv within healthcar system
rank univers
held structur prefer payer-fac subsector faster near-term demand
faster growth howev growth prefer held context growth
momentum market chang macro backdrop us assign greater valu tp rel
safeti unlik prior year outlook less depend end market exposur
focus individu stori top pick rang across subsector
still see fastest growth core payer-fac note certain name subsector
also face outsiz exposur macro includ interest rate unemploy
payer-fac pharma-fac name remain rel prefer growth investor
increment cautiou highest-growth subsector whole
see highest level rel safeti stabil clinic system name ehr
remain core plumb across major provid space allow name
enjoy strong retent rate healthi recur revenu ehr also benefit
matur subsector healthtech space make less depend sizabl new
rank provider-fac healthcar name last among subsector uncertain
macro backdrop could lead delay hospit decis make push back new project
start especi true ancillari tech solut earlier stage less proven
rank stock subsector
forc rank healthcar technolog stock within subsector figur name
greater rel opportun higher list name less rel upsid
lower list
context battleground year healthcar landscap recess fear
upcom elect favor name benefit secular growth trend
overshadow market volatil high level revenu visibl earn upsid
year closest consum see strongest near-term demand
top pick benefit consumer-driven secular stori potenti
upsid estim under-perform cautiou near term
demand ancillari solut face driven paus spend acknowledg
know trajectori shape impact current recess also highlight
safeti pick benefit sticki core solut high
level recur revenu attract yield
figur rank hcit stock subsector
largest end end telehealth providerticker/ratingsectordescriptionbul thesistdoc/opinov/oplvgo/ophmsy/ophqy/mpcern/opcpsi/opmdrx/mpnxgn/mphcat/opchng/oppinc/opphr/op/mpvcra/upveev/mptrhc/opbear thesisonli public pure-play telehealthupsid drive adoptionprovid chronic condit manag solutionssaa data analyt platform sell diversifi client baselead medic safeti softwar servic platformprovid cost contain solut healthcar orgslargest hsa provid accountslargest public provid ehr clinic solut uslead rural commun hospit ehr vendorbroad-bas ehr clinic system providerphysician-fac ehr clinic system platformdata analyt services/platform sell health systemsgroup purchas organ gpo hcit solutionsembed player provid diversifi solut hospitalsprovid patient intak payment process platformsrevenu cycl manag solut providerhealthcar commun workflow solut providerhealthcar commun workflow solut providerhigh valuat ev/revvulner unemploy recessionuniqu dataset replicatedhigh visibl conserv guidancehistor mix execut record competit landscap get crowdedsustain top line growthmix shift driven margin expansionspac get increasingli headwind pacenear term cob upsid medicaidpop health biz reflect headwind payment integritylow expect pop health growthproj premium cdb market growthpotenti upsid wage synergiesmacro headwind low interest ratesgrowth depend wage cross-sellst best breed public ehr playstrong margin improvementsslow growth core ehr marketcross-sel less like due posit nich rural marketcustom least impact recessionslow growth core ehr businesstruebridgecross-sel less like ntsticki stabl core ehr businessupsid veradigmdata monetizationhigh averag risk client attrit spotti execut track recordimprov metric client satisfactionsticki stabl core ehr businessheighten level client attritionlow level new busi bookingslarg grow opp data analyticshigh revenue visibl nimbl platformmor sensit due health system exposur hurt new salessteadi core gpo net posit gpo utilizationweak demand outlook perform servic risk downsidesteadi recur rev embed modelmor flexibl post exitcross sell custom base less like due demand impactonli public pure play marketindustri dynam favor outsourcinghigh valuat ev/revvulner unemploy recessionhypergrowth top-line drive adoptionexposur distress hospitalsout-year growth depend new winslow hospit penetr less impact pullbacksolut priorit hospit ntrecess caus implement delayshigh growth pharma/lif scienc markettam growinghigh valuat nt headwind clinic trialsbenefit hc consumer less threat competitor entranc nt impact payment volumelt threat increas competitionpharma focusedprovid focusedclin system ehrpay focus healthcar technolog
someth everyon
healthcar technolog space matur root pre-profit growth sector
someth everyon divers mix growth even valu
stock combin healthi level capit creation continu tailwind support
greater penetr technolog healthcar increas focu healthcar invest
follow expect heighten level investor interest sector
look heighten sector interest tradit healthcar investor look
rel safeti elect year well pure play tech investor
software-forward ipo space
new ipo creat competit dollar
follow lull healthcar tech ipo made sizabl rebound us
compani came public sector last year total market cap year end
total hcit exit valu year
illustr evolut market cap hcit space figur aggreg
market cap nearli quadrupl sinc despit close market cap taken privat
past year athn abco cotv
trend come put take posit side acknowledg
must wait capit market recov still believ success public offer
pave way healthtech ipo illustr viabl exit strategi ipo
activ could encourag public market investor look hcit space convers
broader set public asset invest creat greater competit public market
dollar contribut have not dynam stock price perform space
stock choos benchmark becom import ad
difficulti stock pick space
figur market cap notabl healthtech stock
garp transit underway ehr
electron health record ehr first public name healthcar sector
meaning use incent spur widespread adopt outsiz growth profil
ehr vendor turn led percept hcit growth sector
ehr market saw tripl threat satur commodit inher
sticki core ehr system drive sharp deceler top line growth despit mani
ehr manag team yet transit away growth compani mindset
result elong disconnect strategi guidanc result
past year seen ehr begin embrac role growth
reason price play within healthcar technolog partial driven evolut
hcit investor base given long road growth expect transit
continu forese futur near term look margin expans cost
optim right-siz spend introduct investor-friendli capit return
program like augment inorgan growth ehr acquir product
adjac easili cross-sold exist client base
success transit unlock signific valuat upsid
look matur vertic platform exampl name trade
shown tabl analysi suggest signific upsid valuat ehr
success execut growth transit
matur vertic name trade averag forward price-to-earnings repres premium
ehr group averag two-turn premium view best
breed public ehr space ebitda basi group trade vs ehr
delta even stagger revenu basi matur platform trade
averag revenu vs ehr lowest multipl matur name
still trade line cern group-high revenu multipl
factset svb leerink
look under-valued asset
compar tradit vertic sector one remark trait hcit space
rel indiffer free cash flow even play space
attribut tendenc ignor yield sector histor pre-profit root
believ combin matur sector threat elong recess bring
yield forefront
rank ehr name yield tabl explor yield
entir hcit coverag tabl page
compani report factset svb leerink estim
expect continu
despit robust year healthcar tech ipo still outpac list nine
time hcit acquisit ipo shown figur compar
saw almost number deal repres compound-annual-growth-rate
figur healthtech privat ipo us europ
attribut continu strength health tech deal flow unpreced level
financi sponsor fundrais earmark digit health deep pocket larg tech
entrant public player healthcar tech space warm inorgan expans
growth expect continu saw greater level particip strateg
acquir expect strateg driven ration valuat recent
market correct season health tech invest financi sponsor could
spur exit
entranc
past year big tech vendor evolv fring news focu item
meaning entrant hcit space
rather compet directli public health tech player larg tech player
approach hcit familiar len
despit alphabet domin tech giant googl direct provid
busi softer expect ramp due brand percept around privaci
led larg unfound concern around data usag comingl core
googl consum data weigh brand valu
amazon web servic aw found traction hcit player cloud
host outsourc ai/deep learn solut meanwhil begun
advertis pillpack solut suggest interest consumer-fac space
continu partner provid healthtech player augment
iphon ipad devic sale posit well virtual care onboard
microsoft azur surpris runaway leader cloud host
sector driven establish reput around cybersecur privaci
impact
healthcar technolog stock median sinc begin march
impact concern major sector platform sold
longer term contract sale model see littl risk core revenu view sell
buy opportun establish high qualiti name space context prefer
name high visibl high retent rate weather uncertainti around book
near term healthi given uncertainti capit market low leverag
despit low level concern core revenu due contractu natur see risk
book new sale activ could mute pandem present greater risk
earlier-stag name within coverag univers often still process
scale note deriv impact could extend book concern throughout
year uncertainti could lead delay decis make push back new project start
look potenti impact subsector
ehr repres risk increment growth retent rate
expect ehr see lower level risk exist revenu base
gener lock multi-year contract see risk book especi
servic side busi salesforc unabl travel deriv
impact pandem provid uncertainti could lead delay decis
make push back new project start outsourc initi
provider-fac similar ehr provider-fac name like see
greater level risk increment growth vs core revenu base howev sinc
mani name provider-fac subsector earlier stage
matur ehr subsector paus book could greater magnitud impact
mani provider-fac solut view ancillari vs core ehr
could result project push
payer-fac push out elect procedur could potenti improv margin near-
term payer earli tell result spend flow-through tech
vendor convers mani payer-fac name index membership
recess could potenti creat attrit headwind name
see broadli benefici virtual care explor
follow section expect near-term boost volum longer
term add effect major increment volum new user
tend continu platform usag onboard
pharma-fac see risk pharma-fac name volume-bas
revenu driven delay clinic trial enrol well trial put paus
pandem could also creat headwind servic revenu implement put
paus delay note signific portion pharma-fac player sell
via all-in enterpris licens contract reduc risk revenu stream
given nascent growth compani natur space much coverag univers
gener posit free cash flow recent investor histor paid less attent
yield within health tech space past expect metric rise import
face recess fear major coverag univers becom posit
rank name yield tabl
compani report factset svb leerink estim
leverag debt mix
given fix cost natur interest payment uncertain macro backdrop rank
name coverag univers rel debt load tabl analysi also includ
mix fix vs float debt recent rate cut potenti lighten compani
compani report factset svb leerink estim
note
interest rate swap fix float debt
convert note hedg price
warrant
note
interest rate cap limit variabl rate max
cap call initi cap price
figur illustr macro exposur compani hcit coverag
univers note full circl factor indic tailwind prefer trait
face recess empti circl indic headwind compani rank order
prefer subsector
stale estim
uncertainti surround impact hcit busi model compani
within coverag univers provid ad hoc updat revis guidanc
alway captur street estim tabl snapshot recent estim revis
reflect whether impact bake street estim compani
number analyst
chang
number analyst
chang ep
winner loser
winner see strongest tailwind greatli increas
import util virtual care lvgo remot solut also benefit
see potenti sleepier stabl name univers re-rat investor
prefer shift toward safeti yield benefit
loser push ancillari tech spend across hospit physician practic could
weigh nich provider-fac name especi depend new win see
greatest risk
virtual becom front mind
expect pace telehealth adopt acceler rapidli
telehealth alreadi experienc favor govern reimburs tailwind exit
pandem sharpli acceler pace posit regulatori chang
posit newsflow reimburs regulatori front includ sharp increas
state medicaid program reimburs telehealth telehealth expans medicar
advantag popul medicar immedi expand coverag telemedicin nationwid
help at-risk senior stay home trump administr waiv state line rule
seen greater provid engag virtual care adopt re-priorit
telehealth top health system to-do list channel check medacorp
specialist shown acceler adopt pace new hospit telehealth solut
time seen mani hospit health system engag virtual-first
strategi coronaviru pandem keep healthi patient popul safe free
capac emerg room resourc consum side also expect steep increas
awar virtual care enter public lexicon first time patient look
way avoid high-risk wait room receiv care practic social distanc
especi true at-risk popul senior patient chronic condit
uniqu group histor view later adopt virtual care
winner loser virtual becom front mind
winner teladoc tdoc/outperform main beneficiari acceler virtual care
trend virtual urgent care volum well hospital-fac busi note
process acquir intouch health expect close end
pure play virtual care platform hospit livongo lvgo/outperform also saw
benefit increas virtual engag chronic care manag platform
depend revenu share agreement may also see benefit ehr
vendor offer telehealth platform
loser reshuffl hospit spend immedi priorit telehealth could weigh
hospital-fac solut elong sale cycl vendor includ
pinc/outperform /market perform hcat/outperform
improv deliveri consum experi
past year mark grow wave consum engag across
healthcar ecosystem sign slow-down attribut heighten level
consum engag marriag two separ trend emerg patient
payer advent high deduct health plan pass greater share
healthcar cost burden directli patient grow consum buy-in well
creat greater engag person health
result past year seen array healthcar technolog solut improv
upon care deliveri look feel lag almost consumer-fac industri due
prior disconnect patient payer seen creation consumer-
face well solut clinic bend boutiqu consumer-ori clinic
fertil acupunctur concierg medicin etc wearabl creat track monitor
healthcar tech brand less clout among consum believ also open
healthcar technolog space tradit consumer-centr tech vendor strong brand
recognit amazon googl other
demand provid extend beyond outcom broader consum
experi provider-fac technolog perspect translat outsiz growth
solut improv upon care deliveri consum experi includ appoint
schedul onboard solut patient portal secur text/email follow up virtual care
solut taken extrem trend could also fuel growth concierg medicin solut
result heighten competit provid rais bar consum experi
payer risk-on provid payvid side heighten patient engag could result
consum turn insur tech-forward solut lower cost streamlin
process also hold payer higher level scrutini around patient satisfact
solut benefit consumer trend includ telemedicin health save
account healthcar navig tool health advocaci program
winner loser improv deliveri consum experi
winner direct beneficiari trend
player solut closest consum patient experi group
diabet manag patient payment
loser believ greater adopt tech key improv consum
experi healthcar mirror industri retail transport payment etc
reduc consum friction tech-en solut said
solut furthest consum less like benefit trend absent
innov group includ ehr
although mani name made earli inroad consumer-
vendor watch amazon googl increas consum engag within
healthcar open play field tradit consumer-centr tech vendor
includ larg tech vendor acut awar
prime posit particip meaning healthcar
past two year includ amzn/pillpack google/fitbit healthcare-fac
cloud strategi microsoft azur aw googl cloud consum face health
solut appl heart studi
chang come healthcar payment
line evolut consumer-fac care deliveri model see greatest amount
near-term disrupt consum payment experi within healthcar
attribut need healthcar payment transform combin put take
consum side includ legaci check paper bill-bas payment system
within healthcar broader evolut consum payment experi industri
auto-bil pay payment portal consum shoulder greater portion
healthcar cost burden bill volum provid side increas portion
consum pocket payment impact collect rate provid typic
collect post-insur balanc consum compar collect rate
payer
beyond market demand believ healthcar payment could see rapid evolut
near term payment incumb enter space recent flywir acquisit
simple februari chase paymentech acquisit juli global
payment acquisit advancedmd septemb could potenti pave way
transact among payment facilit look target untap healthcar
payment opportun meanwhil success smaller health tech innov payment
space zeli cedar could creat fast follow exist hcit vendor
wari deep pocket seen tradit payment player note sell
fragment healthcar end market histor one industri greatest
moat give edg proven health tech player look scale value-ad solut
beyond pure play payment accept key differenti healthcar payment space
could benefit scale hcit player trust brand convers expect
come year around healthcar payment benefit smaller revenu cycl payment
vendor within healthcar technolog space
winner loser chang come healthcar payment
winner see greatest opportun within public privat payment player
healthtech space abl monet trend could prove
attract target larger pure-play payment player look enter
healthcar space phr/outperform pure play payment name
space secondari winner includ clearinghous revenu cycl manag vendor
stand win payment via partnership leverag establish healthcar
relationship vendor includ chng/outperform
loser see risk legaci patient-centr revenu cycl player focu
paper statement call center work evolut healthcar payment
opportun revenue-cycl face player
epic cogniz trizetto busi could also becom risk growth
compani delay invest innov around revenu cycl process see
particular risk mid-cycl revenu cycl manag focus manual
process code reconcili etc workflow
data continu matter
onset meaning use approxim exabyt healthcar data
produc look forward year exabyt healthcar data
project produc creat broad play field opportun data set
boom data store run parallel evolv view data within health tech
univers histor healthcar tech vendor follow epic lead purpos avoid
data monet strategi howev largest data set sit within
compar slower-growth healthcar tech compani see mani hcit vendor
begin explor data monet strategi includ
new entrant look monet data think also rais question
ascrib valu data health data set valuabl rather
stand-alone ehr payer data see greatest valu longitudin data set identifi data
set data set scale believ data wareh player well
data aggreg best posit long term benefit trend near term see
greatest opportun narrow data set depth directli link action
note privaci concern creat risk data monet strategi extrem case
creat headlin risk like project nightingal recent google/ascens partnership
ultim believ advanc data solut necessit collabor
healthcar vendor data store big tech player expertis note
public apprehens around comingl health data tech vendor data brows
histori on-line purchas histori etc could delay pace innov even strict data
silo tech player
winner loser data continu matter
winner see greater near-term opportun industri establish data
warehous includ inovalon inov/outperform hcat/outperform
also see potenti earli mover data aggreg space mdrx
loser data monet field get crowd see greater difficulti new
entrant healthcar technolog space look monet data
addit see less valu dispar data set fragment ehr
ai nlp ml reduc costadmin first
research cite nation academi medicin estim unnecessari
wast spend us healthcar system admin spend account
make largest categori nearli healthcar wast illustr compon
wast spend figur
figur wast spend us healthcar
time rise data healthcar precipit rise data solut includ
artifici intellig ai natur languag process nlp machin learn ml
applic term solut rang virtual chatbot voic technolog predict
analyt tool like watson health believ signific annual administr wast
burden repres largest near-term opportun solut within healthcar
tech innov allow scale autom smaller low-end manual process
contrari market fear around disrupt larg tech entrant partnership hcit
tech provid biggest opportun ai nlp ml believ marriag hcit
player industri expertis data store tech compani intern ip yield
success solut amazon recent deep learn partnership chang
healthcar claim life-cycle ai machin learn ai solut
winner loser ai nlp ml reduc
winner view shift toward autom broadli benefici healthcar
technolog space believ trend favor heighten level tech spend
admin wast prove largest near-term opportun autom believ
player closest healthcar admin wast abl monet trend near
administr wast abus failur system failur coordin healthcar technolog
term vendor closest admin spend includ chng/op hm
loser see greatest risk hcit legaci outsourc manual labor centric
solut includ legaci busi cerner work
busi although true risk see potenti smaller healthcar tech
vendor miss tech partnership trend may look
larg tech vendor evalu potenti partner
cloud final bring secur risk
past two year seen mark chang healthcar stanc toward cloud
comput eric schmidt himss keynot urg healthcar provid consid move
data store cloud vs exist locally-host landscap today cloud penetr
healthcar stand almost provid beyond discoveri
stage cloud strategi
cloud comput come affili cybersecur risk saw record number
ransomwar attack healthcar organ well health record breach interestingli
despit heighten level awar around cybersecur risk healthcar organ
yet see real commerci demand healthcare-centr secur solut
interoper havent heard name year
feder policymak releas new piec interoper regul march bring
subject interoper back forefront follow post-meaning use lull expect
hh interoper rule act catalyst cybersecur solut increas data
sharingespeci less secur front mobil appscould precipit proactiv
demand secur improv
winner loser cloud final bring secur risk
winner larg tech vendor primari beneficiari healthcar
shift cloud microsoft azur amazon web servic prove leader
follow googl cloud distant third cybersecur front public hcit
space continu lag look earli vendor privat sector cleardata
potenti beneficiari trend
loser cloud front see greatest potenti revenu eros legaci
local host solut solut often suppli ehr vendor
includ cybersecur front see near-
term potenti downsid upsid across univers risk data
shown figur strong year healthcar name within
context broader market ralli exclud compani came public mid-year
compani compar hcit univers saw posit
return top perform return
respect
apart ehr name saw larg mute perform flat
hcit name saw sales/contract execut issu intra year
heavili penal weak revenu perform follow launch
new smartbadg product due larg contract loss cvs/aetna
market-cap weight basi index healthcar name return
vs driven outsiz perform larg cap name includ
equal-weight index hcit coverag univers
yield
factset svb leerink research
sector basi market cap-weight hcit index outperform major sector
return figur illustr healthcar sector perform rel
 sector note exclud market cap weight hcit index
still saw healthi return lag technolog
composit hcit svb leerink index includ follow name
shown figur major coverag univers experienc ytd
declin alongsid overal market downturn pandem
seen notabl except declin meaning share ralli
ytd coronavirus-rel shutdown quarantin act tailwind
telehealth adopt share ytd elev membership enrol
engag chronic condit manag platform pandem
look sector broadli name coverag univers seen
ytd declin rang worst perform group ytd
market-cap weight basi index healthcar name ytd vs
 note index valu skew higher out-performance
combin make close half total market
cap index
exclud market weight index hcit univers declin
ytd beat russel equal-weight index
hcit coverag univers ytd
market cap-weight hcit index outperform major sector ytd return
illustr figur note larg cap outperform
skew metric exclud health tech univers saw middl
pack return market cap weight declin
composit hcit svb leerink index includ follow name
deconstruct share price perform tabl compar overal return
underli revenue/ep growth multipl expans
mix year hcit multipl expans context posit stock price
perform name compar coverag univers ex ipo saw stock price
appreci saw multipl expans multipl expans greatest
multipl contract greatest
multipl expans greatest follow
subsector perspect pharma face group saw greatest level
multipl expans follow clinic system group increas
driven
multipl contract greatest follow
note multipl contract larg driven poor sale
execut follow new product launch smartbadg trhc multipl
push follow loss larg contract cvs/aetna overal provid
face group saw largest multipl contract driven
health valuat right multipl
healthcar technolog compani often stand uniqu confluenc public market given
nascent busi model brief public compani oper record dearth
publicli trade comp time predominantli pre-ipo natur sector
result high level capit creation past year result one
frequent ask question within healthcar technolog right multipl
valuat framework often reli follow factor
histor valuat exist public comp set valuat primari deriv
look compani histor trade multipl put current multipl
context absent mark chang busi model histor level provid
guidepost compani oper nich busi segment subsector albeit
limit mani public compani never trade recessionari
end market dynam secondari valuat approach look compani
len end market peer payer-fac provider-fac pharma-
face cross-subsector busi model may dinner standard recent
demand trend level spend
steadi state analysi healthcar technolog nascent space result
featur primarili early-stag pre-profit compani rather sole focus
top line growth believ prudent take holist approach factor
compani long-term margin potenti view matur servic vertic
fintech payment hr outsourc etc use benchmark analysi
 comp histor comp serv weak benchmark
publicli trade health tech name seen greater valu recent year
increas frequenc deal flow privat equiti take activ role
histor valuat multipl analysi time seri
tabl present snapshot annual forward multipl across hcit coverag
univers well sector median averag
look across entir healthcar technolog univers multipl contract sinc
clinic systems/ehr valuat ration slow growth industri matur
howev subsector basi seen multipl expans payer-fac space given
influx ipo ytd multipl compress continu pullback mani
name approach trough multipl
note group averag median calcul use price-to-earnings multipl
sector perform recess
believ prudent look sector recessionari len follow recent macro
event surround particularli relev name
healthcar technolog coverag univers never publicli trade recess
look sector trough multipl downsid risk tabl appli name
trough trade multipl current forward estim singl stock basi lowest
level trough multipl downsid compar group averag downsid
current trade level name highest downsid risk includ
subsector lowest level risk ehr
potenti downsid note ehr previous weather recess subsector
downsid pharma-fac name risk
impli price
trough multipl
factset svb leerink estim
vertic servic studi
healthcar technolog name publicli trade last recess
creat high uncertainti risk major hcit space downturn
look publicli trade vertic platform recess risk case studi
financi crisi stabil vertic name allow still command
across sector name weather prior recess seen
vertic name trade closer follow recent pullback
appli coverag univers tabl averag analysi yield
approx point recessionari downsid risk univers greatest level
downsid pharma face payer face subsector yield downsid
respect singl stock basi yield largest downsid risk
yield downsid risk trough
note analysi sole appli vertic sector averag acknowledg
certain best breed player continu trade premium throughout recess
revenu
tabl hcit coverag univers potenti downsid vertic case studi
impli price
factset svb leerink estim
factset svb leerink estim
valu base
compani report capit iq svb leerink estim
reason report
best breed discount
initi outperform rate price target
bottom line recess look stabl best breed
core platform play rel safest play believ
despit share trade price-to-earnings
compani recent low late march still
averag strong leverag
oper improv stori think within control see
one top posit name within coverag univers
come year believ low risk downsid support
outperform rate pt
domin public player high end ehr market
hospit ehr busi rapidli becom duopoli
market either publicli trade privat held epic sticki
lt debt total capit
embed natur larg ehr instal put enviabl
posit weather downturn view high retent rate
vertic recessionari case studi platform revenu
rare declin use best breed vertic
perform case studi recess
despit outsiz pressur vertic financi employ
end market note revenu growth remain posit
underscor embed safeti cern platform model
oper improv initi put key focu item
cern control believ achiev cern oper
improv initi posit compani reshap
stori around metric within intern control environ
extern factor remain unknown see potenti upsid
cern op margin target support
compani inform svb leerink llc note reflect gaap revenu adj ep
signific runway left outsiz spend premium margin
vertic platform peer
valuat recov low current trade
ep recov trough multipl forward
ep late march price target appli
multipl ep line cern current trade
multipl well compani pre-covid trade level
reason report
recur plumb strong
initi outperform rate pt
bottom line think compel safeti play
uncertain macro backdrop compani function
embed player healthcar system enjoy recur
revenu strong gener despit attract
characterist chng valuat bottom coverag
univers given compani high leverag profil view
derisk given strong investor assign low probabl
success turnaround execut outlook predic
lt debt total capit
full turnaround growth compani well posit weather
macro storm initi coverag outperform rate
exit rearview complet split-off
stake ownership earli march elimin signific
overhang share larg lost pandem fear
engulf market note stand-alone
transact flexibl go forward recal erx option believ
compani unlock upsid via proactiv manag portfolio
recur durabl embed model think chng
busi model strong downturn diversifi custom
base includ hospit provid almost payer
embed relationship built core clearinghous busi
stabl revenu foundat high retent recur
outlook predic full turnaround estim
reflect out-year revenu growth repres low end chng
outlook howev believ combin de-lever
compani inform svb leerink llc note reflect gaap revenu adj ebitda
margin expans consolid synergi remain
margin expans allow enjoy high singl
digit earn growth potenti upsid transact
find cheap metric upsid share
use sotp trade bottom quartil coverag
univers price-to-earnings ebitda pt assum
sole trade ev/ebitda base sotp analysi
reason report
comput program system
posit rural small hospit market
initi outperform rate price target
bottom line lead ehr vendor small rural hospit
space limit recessionari downsid initi coverag
outperform rate price target given
rural hospit market long distress prior
covid cpsi tough end market exposur histor bake
compani below-p trade multipl therefor
believ cpsi rural hospit end market pressur
believ cpsi downsid recess limit
potenti upsid near-term rural hospit receiv
feder state govern support combat pandem
pressur put damper new win believ
longer term uniqu posit fill competit vacuum left
lt debt total capit
athenahealth expect share gain provid
distress end market done cpsi core ehr
busi target commun hospit bed special
bed hospit make ehr client base
acknowledg on-going health crisi put strain
rural small hospit market number commun hospit
push brink insolv howev note market
segment long econom depress prior pandem
distress end market risk alreadi price cpsi
below-p trade multipl histor turn discount ehr
averag addit cpsi end market risk mitig due client
mix half current client base design critic
access hospit receiv feder fund would like receiv
govern support combat pandem
compani inform svb leerink llc note reflect gaap revenu adj ep
impact ehr replac demand view
highli favor competit posit longer term larg ehr player
athenahealth exit downstream market
potenti sunset product given financi profil
geograph isol target custom base view unlik
small rural hospit would go up-market vendor epic
focu vendor consolid like prefer ehr
replac option similar slightli higher price point
addit note price leader athenahealth exit
gain addit price leverag replac deal
multipl ep target multipl repres
low end ehr trade univers ex-cpsi line
cpsi trade averag past year compani begin
execut still even discount multipl price target repres
upsid support op rate
reason report
approach provid analyt
initi outperform rate price target
bottom line leader larg grow market opportun
high visibl cap downsid oper cloud-bas
data analyt software/servic platform sold hospital/health
system end market believ overarch theme
data analyt solut penetr healthcar
place hcat solut step peer attribut
nimbl core data platform built ground hcat data
wareh root narrow focu measur roll-out
applic allow tailor solut vs much
think industri approach throw wall see
stick approach analyt help analyt solut
gain provid mindshar compani benefit revenu
lt debt total capit
visibl revenu retent initi outperform
rate price target
data analyt grow import act
acceler although see time risk around margin
new win net posit demand hcat core data analyt
solut pandem capacity/suppli manag
admiss project activ roll
impact plan believ could serv entryway
hcat broader solut suit pandem begin eas
convers medacorp specialist point
grow provid awar need analyt light
tout visibl revenu built compani
recur platform model remain revenu compris
compani inform svb leerink llc note reflect gaap revenu adj ebitda
new softwar book new win profession servic
hcat long term softwar sale cycl one year give us
comfort revenu guidanc assum
achiev visibl revenu would still impli doubl digit
growth view attract lower bound
signific discount ipo valuat trade
revenu well valuat throughout
reason level long-term double-digit grower howev
compani recent pull guidanc target multipl sole reflect
half turn premium current level reach price target
even conserv valuat math note
price target still repres nearli upsid current level
reason report
stabl base multipl shot goal
initi outperform rate price target
bottom line posit hmsi cob pi stabil
multipl shot goal upsid initi coverag
outperform rate price target
view compani core cob busi rev steadi low
risk revenu base see multipl shot goal out-performance
across subseg pi side rev convers
medacorp specialist highlight potenti time
impact chang overal pi demand cob see potenti
upsid medicaid expans driven final
acknowledg gap pop health perform past year
note valuat assign almost valu asset creat free
lt debt total capit
call option new sale leadership abl execut
stabl revenu base cob potenti near-term medicaid
upsid origin state medicaid cob coordin
benefit provid continu oper natur monopoli
busi due extens data histori state
platform remaind run cob hous domin
posit could limit cob long-term growth profil low mid-
singl digit note busi could benefit near-term
upsid medicaid expans driven upcom
pop health busi reflect current trade level
expand platform care manag member
engag popul risk acquisit essett
eliza launch elli pop health growth took
signific step back drop prior double-digit
compani inform svb leerink llc note reflect gaap revenu adj ebitda
cadenc valuat follow lockstep trade
pre-pop health level posit segment growth outlook
new sale leadership helm view pop health free
valuat call option get growth back track
price target current trade
ebitda well compani trade averag
execut misstep busi see long road
ahead regain investor trust success execut
result sole appli one turn premium reach
price target
manag cite lower pi side
total revenu
reason report
execut lt hsa thesi
initi market perform rate price target
bottom line market perform fault
outsiz macro headwind continu believ hqi
multi-year thesi broad hsa adopt market perform
compani outlook due outsiz exposur macro factor
lt debt total capit
includ interest rate unemploy market pullback
model top line growth year degrad high
margin custodi revenu make difficult argu multipl
expans near term even synergi surpris upsid
interest rate repres revenu headwind out-year
model headwind growth headwind
declin interest rate bring hqi growth low
mid-singl digit exacerb custodi fee headwind
pullback market neg impact invest aum note
deceler come cost high decrement margin
custodi fee estim repres drag
margin
still project account growth premium cdb market
believ pois consolid hsa share via premium
consumer-align product full suit consum direct benefit
cdb offer follow wage acquisit consolid could
acceler pick-up hsa portfolio valuat
ration rate pull
expect synergi upsid hqi synergi target repres
wage revenu base well histor platform
servic synergi averag although lower yield could
pressur busi optim synergi reinvest wage
compani inform svb leerink llc note reflect gaap revenu adj ebitda
asset continu believ target skew
price target trade ebitda
well trade averag past year
histor ebitda averag pre-wag note trade
signific premium mid-singl digit top line growth peer
given strong multi-year thesi hsa penetr believ
premium merit find hard argu meaning multipl
expans battl macro headwind sole appli half
turn multipl premium ebitda reach price
reason report
posit uniqu dataset high visibl
conserv guidanc
initi outperform rate price target
bottom line like strong execut high visibl
healthi believ underappreci conserv
guidanc philosophi transit data
platform/intervent outsourc medicare/medicaid client
saa data analyt platform sell diversifi client base
shift strategi allow compani enjoy high visibl
subscription-bas revenu pair compani newli
conserv approach guidanc posit compani
achiev beatabl estim combin discount
valuat given back entireti post-transit ralli
posit near-term outlook share initi
uniqu dataset believ replic today
enter data aggreg busi pre-hipaa give compani
data store access identifi primari sourc longitudin match
record patient post-hipaa world view
almost insurmount moat put head pack
data monet play healthcar tech
conserv guidanc philosophi bias estim upsid
view inov guidanc impli top line growth
compani recent growth clip prudent conservat
believ strategi particularli well appreci rocki
tape could support expans inov multipl
multipl ebitda line sotp hcit peer
lt debt total capit
compani inform svb leerink llc note reflect gaap revenu adj ebitda
valuat inov payer provid end market
note valuat give full credit pharma/lif
scienc end market success execut busi
key unlock upsid
reason report
risk revenu model high risk patient
initi outperform rate price target
bottom line unshak core market high revenu
visibl oper chronic condit manag platform
sold employ payer end market major
platform focus diabet manag lvgo larg grow
under-penetrated give us assur unstabl macro
backdrop compani high retent subscript model give
us confid lvgo top-quartil growth outlook think
enviabl posit command premium valuat
price target reflect multipl revenu
lt debt total capit
diabet end market offer stabl ground although
diversifi chronic care adjac compani core diabet
spend market larg grow growth
under-penetrated mani name coverag univers
could see recessionari impact paus end market spend
view increas preval diabet unwav fact
independ market acknowledg uptick
unemploy could increas lvgo churn believ scale
diabet well penetr chronic condit
market off-set employe turnov
outsiz growth high level visibl enjoy
retent recur subscript revenu model give compani
visibl year revenu growth visibl support
penetr exist client allow compani enjoy
top quartil revenu growth model relianc
new client win shield compani expect
impact remot support high-risk popul
compani inform svb leerink llc note reflect gaap revenu adj ebitda
lvgo remot support model allow minim platform
disrupt pandem high-risk natur
compani patient popul improv membership
engag dynam allow rais revenu
guidanc de-risk stori rocki tape
premium valuat peer discount histori
command fastest growth profil space annual
revenu growth despit name trade
top sectorlvgo trade revenu
repres two-turn premium broader payer face space
averag pt appli multipl
revenu repres upsid independ multipl
reason report
sidelin show stori
initi market perform rate price target
bottom line cheap ye wait execut
trade long-term justifi level ehr
believ stock could remain rangebound compani
establish execut track record fundament like
sticki stabil ehr busi face recess
attrit headwind grow-ov recent misstep
veradigm busi make show stori
stabl ehr busi off-set higher retent risk like
recur embed natur ehr busi uncertain
macro backdrop believ command less stabil
premium owe higher attrit rate peer lower renew
rate could becom especi relev recess
tougher come new sale grow attrit
veradigm execut could tip scale veradigm mdrx
lt debt total capit
payer/lif scienc repres crossroad compani build
path higher-growth/high margin payer life scienc end
market success execut could make us revisit market perform
rate like mdrx earli mover advantag data monet
believ size market opportun acknowledg
mdrx current trade level assign almost valu high growth
busi top line growth time soft
segment result reset momentum build throughout keep
us gain comfort growth target
ep estim line mdrx current trade
multipl well ehr peer averag appli
three-turn discount peer due mdrx rel higher attrit risk
compani inform svb leerink llc note reflect adj revenu adj ep
inconsist execut track record acknowledg potenti
upsid compani simpli meet expect
reason report
cautiou acceler ehr remain
initi market perform rate price target
bottom line end market limit year growth protect in-
year growth fundament believ abl
achiev high singl digit year growth target backdrop
fulli satur ehr end market said nxgn valuat
ration sinc earli day turnaround longer
believ market give compani credit year growth
acceler forward price-to-earnings nxgn sleepi ehr
end market make difficult growth acceler stori make
defens stori recess support market perform
cautiou year growth ramp guid high
singl digit year growth sinc begin sinc
moder mid high singl digit growth target
acknowledg execut well earli stage
turnaround revenu contract posit organ growth see
difficult path mid high singl digit growth given satur ehr
end market wallet growth discount compani
target note fulli penetr vertic tend grow low
mid- singl digit make tough cross-industri case studi
end market put take ehr end market stabl sticki
fulli penetr reliant cross sale characterist
make hard meaning acceler top line growth
characterist also make reason defens play
recess although nxgn smb end market leav compani
expos macro upmarket ehr peer core ehr focu still
lt debt total capit
compani inform svb leerink llc note reflect gaap revenu adj ep
posit compani favor rel basi across coverag
current trade forward ep repres signific
discount averag moder year growth
target despit discount histor level still trade
turn premium broader ehr subsector despit organ growth
lag peer result price target sole roll
reason report
bring integr payment process
initi outperform rate price target
lt debt total capit
bottom line chang come healthcar payment
think lead way direct beneficiari
healthcar consumer trend patient intak payment
process platform bring healthcar speed broader
consum experi market simultan eas admin burden
provid expect increas competit healthcar
payment market long run note healthcar tend
rel insular market favor incumb like
share take breather near-term volum pushout
see valuat opportun support outperform rate
direct beneficiari consumer healthcar
oper lead patient intak payment process platform
put compani crossroad healthcar
consumer payment transform phr solut help
eas administr burden provid client time
collect rise import advanc healthcar
consum payment experi line consumer-
attract merchant acquir busi model major
phr busi rev oper merchant acquir
busi model compani earn gross discount rate
across client payment volum busi model character
healthi growth benefit payment electronif well high
increment margin volum upsid would group
openedg compani also offer integr busi manag
compani inform svb leerink llc note reflect gaap revenu adj ebitda
softwar command premium valuat pure play merchant
near term impact payment volum off-set
soften competit environ push elect
procedur creat near-term headwind phr payment volume-
driven top line revenu believ bake
stock follow phr file volum declin believ push
elect procedur question time dissip
demand expect abl make major
lost revenu follow pandem competit front expect
less near term threat larg payment incumb enter
healthcar space given uncertainti provid market
valuat opportun disrupt current
trade revenu well averag
payment volum disrupt pandem price
target sole roll forward current trade multipl
revenu expect payment volum uncertainti persist
near term line re-rat seen merchant acquir
peer sq noth fundament broken phr busi
model believ valuat like re-rat volum return
see signific long-term opportun disconnect
reason report
gpo steadi goe bar
initi outperform rate price target
bottom line posit pinc core gpo busi
relat believ valuat alreadi reflect low expect
ps busi pinc final member-own exchang year
october/novemb end overhang share give
compani greater cash flexibl may help stock re-rat
investor begin appreci top quartil yield
gpo busi provid stabl base sole time risk
pinc suppli chain servic busi rev oper
primarili group purchas organ provid stabl mid-
singl digit growth revenu base compani gpo
busi enjoy share shift satur end market uptick
downtick growth often function util downtick
elect procedur could headwind busi near term
see question time believ pinc gpo
see net posit impact util impact
cautiou demand outlook perform servic pinc
support consult servic incumb provid client base
posit pinc embed relationship provid
client cautiou near-term demand environ
ancillari hospit solut model declin ps revenu
low end compani guidanc see risk
downsid current macro environ persist
strong gener new cash opportun
lead pinc yield howev believ investor often
lt debt total capit
compani inform svb leerink llc note reflect gaap revenu adj ep
discount pinc due compani member-own up-c
structur limit use cash pinc final member-own
exchang come october/novemb believ compani
gain signific flexibl cash prioriti includ potenti
dividend buyback scale
valuat point limit downsid current trade
ep near histor low march
ev/ebitda basi trade impli almost
valu ps businesspinc trade ebitda gpo
busi alon vs peer medasset takeout valuat ebitda
price target appli multipl ep
repres two turn premium current level expect
unlock valu use cash still repres half turn
discount pinc trade level
reason report
strong execut cautiou new wins-driven
initi market perform rate price target
bottom line strong execut expect risk npr
year growth oper largest independ end-to-end
revenu cycl manag provid us make chief
beneficiari favor outsourc industri dynam recent
year fundament like execut posit
within end market cautiou compani near-term
book given uncertain macro environ reshuffl
mindshar scale provid rcm out-year growth predic
in-year new win remain sidelin initi market
risk estim year growth depend
new win proven record execut ramp exist
client contract see risk npr execut
number howev rcm year growth highli depend
prior year book assum new win would impli mid-
singl digit revenue growth could weigh valuat
risk end market pressur demand put
pressur hospit health system financ see risk
rcm provid end market especi true financi
pressur provid tend favor outsourc sourc cost
save compani may contract quorum health
provid explor potenti chapter bankruptci
industri dynam continu favor outsourc
forecast doubl digit industri growth revenue cycl outsourc driven
increas complex payment model continu trend
lt debt total capit
compani inform svb leerink llc note reflect gaap revenu adj ebitda
consumer creat greater demand eas payment
health system revenu margin pressur could
exacerb
price target trade ebitda
base fulli dilut share count use compani report
share use fulli dilut figur compar histor
trade estim repres signific discount rcm
trade averag past year note still repres
premium provider-fac peer despit similarli challeng
end market price target assum one turn multipl
compress heighten out-year estim risk appli
target multipl ebitda
reason report
clear winner secular shift virtual
initi outperform rate price target
bottom line unquestion leader secular
growth industri first largest end end provid
telemedicin solut us rang extend virtual
urgent care begin behavior health inpati virtual care
platform chronic diseas manag
compani well posit domin space transform
way patient consum healthcar longer term initi
outperform rate price target
lt debt total capit
acceler model highli recur name
within coverag univers may low-risk respect
ensu macro pullback name directli
benefit pandem believ creat signific
upsid number includ util daili visit
week/week mid-march primarili new user membership
management cite uptick new wins/inbound request
near-term number believ pandem act acceler
consum awar virtual care propel tdoc adopt curv
year forward may extend run public pure
play telehealth capit market improv maintain
compani premium valuat due scarciti valu
bake current level order trade line
past averag would impli revenu figur
estim pf intouch
believ achiev impli increment util
member plu acquisit line recent cadenc
acknowledg biggest risk share valuat
recent promin virtual care caus share veer stori
compani inform svb leerink llc note reflect gaap revenu adj ebitda
valuat high end peer group trade
revenu near top hcit peer group rang
revenu although believ bias upward earn
revis come year price target appli
multipl revenu line current level
re-rat pandem hesit argu
multipl expans instead believ like grow
multipl come year
reason report
initi outperform rate price target
trade discount high-growth peer oper peer-
lead medic safeti manag platform sold primarili
pace program all-inclus elderli mtm emtm
mitig stori remain intact independ macro see clear
path growth mid-term high degre visibl
trade nearli two-turn discount high growth
peer initi outperform rate pt impli
lt debt total capit
long runway core pace opportun upsid beyond
pace see build sustain top line growth
driven organ growth pace growth
opportun outsid pace mtm emtm ehr expans etc
tuck
mix shift driven margin expans pace repres
revenu well mix ipo expect
mix shift continu creat built margin expans given
higher margin profil non-pac revenu softwar margin
mtm margin vs gross margin pace next
year forecast gross margin adj ebitda
margin repres annual margin expans
price target current trade ntm
revenu line histor averag revenu
two turn high growth hcit peer top line
price target appli multipl revenu effect
compani inform svb leerink llc note reflect gaap revenu adj ebitda
reason report
cautiou near term hospit ancillari
initi under-perform rate price target
lt debt total capit
bottom line cautiou near-term potenti
repriorit hospit spend could weigh demand
compani core commun platform compani
compar elev valuat revenu half turn
discount limit upsid support under-perform rate
reshuffl hospit prioriti could impact commun
demand posit vcra evolut stand-alone
commun badg compani broader commun platform
believ commun overal could rerat lower context
hospit budget pandem
near-term demand solut like telehealth virtual care take greater
share draw parallel shortcom vcra end market
demand meaning use cautiou new sale
macro uncertainti could weigh new project start
shift sale process toward larger new custom win vs prior
land expand strategi led healthi doubl digit
book cadenc also lead lumpi risk
signific decis could push hospit uncertain
valuat less impact market pullback one
five name coverag univers year albeit
lower base given compani downward guidanc revis
throughout still put vcra ev/rev multipl
line averag suggest less room upward multipl
compani inform svb leerink llc note reflect gaap revenu adj ebitda
revis rel broader hcit sector pt appli
multipl revenu estim reflect multipl compress
demand push out
reason report
industri leader life scienc
valuat match
initi market perform rate price target
bottom line like veev growth prospect market opp
valuat keep us sidelin lead cloud solut
vendor high growth pharma/lif scienc industri allow
compani enjoy premium growth margin profil top
ebitda although believ veev strong competit
posit allow compani expand busi across
pharma/lif scienc end market stay sidelin
compani grow valuat
industri leader high growth pharma/lif scienc
end market oper lead saa platform provid
life scienc industri offer across commerci pharma
rep develop clinic trial manag side
busi posit veev domin market share posit
commerci busi leav compani well posit
grow across adjac premium growth pharma/lif scienc
end market fuel organ revenue growth project
grow came public
sinc doubl expand adjac product
line expect cadenc continu recent
introduct data cloud support compani revenu target
scienc compani paus clinic trial light on-going
pandem see risk new sale clinic data manag
system cdm revenu tie volum
enjoy high visibl subscript busi note
lt debt total capit
compani inform svb leerink llc note reflect gaap revenu adj ebitda
veev servic busi total revenu recur
could weigh near-term outlook uncertainti persist
price perfect premium valuat initi
pt price target appli multipl revenu
estim line veev averag forward multipl past two
year current trade revenu well
group median repres high end hcit univers
believ high valuat justifi given veev exposur
premium growth end market find difficult argu multipl
expans near term given uncertain macro outlook near-term
headwind clinic trial instead believ grow
recess look stabl best breed core platform play rel safest play
believ despit share trade price-to-earnings
compani recent low late march still averag
strong leverag oper improv stori think within control
see one top posit name within coverag univers come year
believ low risk downsid support outperform rate pt
current trade ep recov trough multipl forward
ep late march price target appli multipl ep
line cern current trade multipl well compani pre-covid
trade level
downsid risk estim price target includ
push feder ehr contract ramp va dod shift prioriti personnel
spend post
lower expect book due provid spend shift post
think compel safeti play uncertain macro backdrop compani
function embed player healthcar system enjoy recur
revenu strong gener despit attract characterist chng valuat
bottom coverag univers given compani high leverag profil
view derisk given strong investor assign low probabl success
turnaround execut outlook predic full turnaround growth
compani well posit weather macro storm initi coverag outperform
rate price target
trade bottom quartil coverag univers price-to-earnings
ebitda pt assum sole trade ev/ebitda base sotp
downsid risk estim price target includ
short execut histori new manag team
failur execut turnaround ancillari busi
lead ehr vendor small rural hospit space limit recessionari downsid
initi coverag outperform rate price target given
rural hospit market long distress prior covid cpsi tough end market
exposur histor bake compani below-p trade multipl therefor
believ cpsi rural hospit end market pressur
believ cpsi downsid recess limit potenti upsid near-
term rural hospit receiv feder state govern support combat pandem
pressur put damper new win believ longer term
uniqu posit fill competit vacuum left athenahealth expect share
gain provid spend environ improv
price target appli price-to-earnings multipl ep target
multipl repres low end ehr trade univers ex-cpsi line cpsi
trade averag past year compani begin execut still even
discount multipl price target repres upsid support op rate
downsid risk estim price target includ
rural small hospit fall bankruptci due event feder state
govern support insuffici
lower expect demand trubridg cross-sel due provid budgetari concern
leader larg grow market opportun high visibl cap downsid
oper cloud-bas data analyt software/servic platform sold hospital/
health system end market believ overarch theme data analyt
solut penetr healthcar place hcat solut step peer
attribut nimbl core data platform built ground hcat
data wareh root narrow focu measur roll-out applic allow
tailor solut vs much think industri approach throw
wall see stick approach analyt help analyt solut
gain provid mindshar compani benefit revenu visibl
revenu retent initi outperform rate price target
trade revenu well valuat throughout
reason level long-term double-digit grower howev compani recent pull
guidanc target multipl sole reflect half turn premium current level reach
month price target even conserv valuat math note price
target still repres nearli upsid current level
downsid risk estim price target includ
slow neg new sale growth due health system budgetari concern spend
prioriti shift post
push implement new project due impact top line
posit hmsi cob pi stabil multipl shot goal upsid
initi coverag outperform rate price target view
compani core cob busi rev steadi low risk revenu base see
multipl shot goal out-performance across subseg pi side
rev convers medacorp specialist highlight potenti time impact
chang overal pi demand cob see potenti upsid medicaid expans
driven final acknowledg gap pop health perform past
year note valuat assign almost valu asset creat free call option new
sale leadership abl execut
current trade ebitda well compani trade averag
execut misstep busi see long road ahead
regain investor trust success execut result sole appli one turn
premium reach price target
downsid risk estim price target includ
declin payment integr revenu post due provid friction
lower expect pop health growth payer shift spend prioriti post
market perform fault ownouts macro headwind continu
believ hqi multi-year thesi broad hsa adopt market perform
compani outlook due outsiz exposur macro factor includ interest
rate unemploy market pullback model top line growth
year degrad high margin custodi revenu make difficult argu multipl
expans near term even synergi surpris upsid
trade ebitda well trade averag
past year histor ebitda averag pre-wag note trade signific
premium mid-singl digit top line growth peer given strong multi-year thesi hsa
penetr believ premium merit find hard argu meaning
multipl expans battl macro headwind sole appli half turn multipl
premium ebitda reach price target
downsid risk estim price target includ
failur execut wage busi optim synergi
lack demand wage cross-sel especi commut benefit post
upsid risk estim price target includ
gain share small mid size employ market via wage cross-sel
like strong execut high visibl healthi believ
underappreci conserv guidanc philosophi transit data platform/
intervent outsourc medicare/medicaid client saa data analyt platform
sell diversifi client base shift strategi allow compani enjoy high visibl
subscription-bas revenu pair compani newli conserv
approach guidanc posit compani achiev beatabl estim combin
discount valuat given back entireti post-transit ralli
posit near-term outlook share initi outperform rate
pt appli multipl ebitda line sotp hcit peer
valuat inov payer provid end market note valuat
give full credit pharma/lif scienc end market success
execut busi key unlock upsid
mix execut record inabl achiev target doubl digit revenu growth target
competit space get crowd hcit player look monet data
unshak core market high revenu visibl oper chronic condit
manag platform sold employ payer end market major platform
focus diabet manag lvgo larg grow under-penetrated give
us assur unstabl macro backdrop compani high retent subscript
model give us confid lvgo top-quartil growth outlook think enviabl posit
command premium valuat price target reflect multipl
command fastest growth profil space annual revenu growth
despit name trade top sectorlvgo trade
revenu repres two-turn premium broader payer face space
averag pt appli multipl revenu
repres upsid independ multipl expans
downsid risk estim price target includ
member drop platform post due inabl stick program lack
exist member drop platform due unemploy recess
cheap ye wait execut trade long-term justifi
level ehr believ stock could remain rangebound compani establish
execut track record fundament like sticki stabil ehr busi
face recess attrit headwind grow-ov recent misstep
veradigm busi make show stori
price target appli multipl ep estim line mdrx
current trade multipl well ehr peer averag appli three-turn
discount peer due mdrx rel higher attrit risk inconsist execut track
record acknowledg potenti upsid compani simpli meet expect
downsid risk estim price target includ
level new busi book due macro factor lack provid demand
upsid risk estim price target includ
out-performance veradigm data monet strategi
end market limit year growth protect in-year growth fundament believ
abl achiev high singl digit year growth target backdrop
fulli satur ehr end market said nxgn valuat ration sinc
earli day turnaround longer believ market give compani credit
year growth acceler forward price-to-earnings nxgn sleepi ehr end
market make difficult growth acceler stori make defens stori
recess support market perform rate
current trade forward ep repres signific discount
averag moder year growth target despit discount histor
level still trade turn premium broader ehr subsector despit organ
growth lag peer result price target sole roll forward nxgn
downsid risk estim price target includ
level new busi book due macro factor lack provid demand
upsid risk estim price target includ
surpris new book driven out-performance client satisfact demand
chang come healthcar payment think lead way
direct beneficiari healthcar consumer trend patient intak payment
process platform bring healthcar speed broader consum experi
market simultan eas admin burden provid expect increas
competit healthcar payment market long run note healthcar tend
rel insular market favor incumb like share take
breather near-term volum pushout see valuat opportun support
current trade revenu well averag payment
volum disrupt pandem price target sole roll forward
current trade multipl revenu expect payment volum uncertainti
persist near term line re-rat seen merchant acquir peer sq
noth fundament broken phr busi model believ valuat like re-
rate volum return see signific long-term opportun disconnect
downsid risk estim price target includ
larger expect impact payment volum post
larg payment process compani enter competit landscap take share
posit pinc core gpo busi relat believ valuat alreadi
reflect low expect ps busi pinc final member-own exchang year
october/novemb end overhang share give compani greater cash
flexibl may help stock re-rat investor begin appreci top quartil yield
current trade ep near histor low march
ev/ebitda basi trade impli almost valu ps busi
trade ebitda gpo busi alon vs peer medasset takeout valuat
ebitda price target appli multipl ep repres
two turn premium current level expect unlock valu use cash
still repres half turn discount pinc trade level
downsid risk estim price target includ
lower expect perform perform servic
hospit health system decid insourc vs renew gpo contract creat
price pressur gpo contract renew
strong execut expect risk npr year growth oper
largest independ end-to-end revenu cycl manag provid us make
chief beneficiari favor outsourc industri dynam recent year
fundament like execut posit within end market cautiou
compani near-term book given uncertain macro environ reshuffl
mindshar scale provid rcm out-year growth predic in-year new win
remain sidelin initi market perform rate
trade ebitda base fulli dilut share count use
compani report share use fulli dilut figur compar histor
trade estim repres signific discount rcm trade averag
past year note still repres premium provider-fac peer
despit similarli challeng end market price target assum one turn multipl
compress heighten out-year estim risk appli target multipl
downsid risk estim price target includ
distress health system client quorum becom insolv
failur win new oper partnership contract
upsid risk estim price target includ
surpris win new oper partnership contract
margin expans upsid on-going ml/ai-driven cost reduct initi
unquestion leader secular growth industri first largest end
end provid telemedicin solut us rang extend virtual urgent
care begin behavior health inpati virtual care platform chronic
diseas manag compani well posit domin space
transform way patient consum healthcar longer term initi outperform rate
price target
trade revenu near top hcit peer group rang
revenu although believ bias upward earn revis
come year price target appli multipl revenu line
current level re-rat pandem hesit argu
multipl expans instead believ like grow multipl
downsid risk estim price target includ
multipl compress due overal market downturn
loss member due employ reduc workforc recess
peer lead medic risk manag solut trade discount high-growth peer
oper peer-lead medic safeti manag platform sold primarili
pace program all-inclus elderli mtm emtm end market believ
trhc secular ade advers drug event mitig stori remain intact independ
macro see clear path growth mid-term high degre visibl
trade nearli two-turn discount high growth peer initi
outperform rate pt impli upsid
current trade ntm revenu line histor averag
revenu two turn high growth hcit peer top line price
target appli multipl revenu effect roll forward current level
downsid risk estim price target includ
impact pace enrol
competit pressur new entrant
cautiou near-term potenti repriorit hospit spend could
weigh demand compani core commun platform compani
compar elev valuat revenu half turn discount limit
upsid support under-perform rate pt
one five name coverag univers year albeit
lower base given compani downward guidanc revis throughout still put
vcra ev/rev multipl line averag suggest less room
upward multipl revis rel broader hcit sector pt appli multipl
revenu estim reflect multipl compress demand push out
upsid risk estim price target includ
surpris new contract win
increas adopt solut feder market
like growth prospect market opp valuat keep us sidelin
lead cloud solut vendor high growth pharma/lif scienc industri allow
compani enjoy premium growth margin profil top ebitda although
believ veev strong competit posit allow compani expand busi
across pharma/lif scienc end market stay sidelin compani
grow valuat
price target appli multipl revenu estim line veev
averag forward multipl past two year current trade
revenu well group median repres high end hcit univers
believ high valuat justifi given veev exposur premium growth end
market find difficult argu multipl expans near term given uncertain macro
outlook near-term headwind clinic trial instead believ grow
upsid risk estim price target includ
surpris new contract win
increas adopt solut feder market
million except per share data
revenu
adj sale client servic ex sbc
adj gener administr ex sbc
non- reconcili
incom tax effect adj
restructur expens
compani inform svb leerink llc
million except per share data
softwar analyt revenu
oper
research develop
sale market gener administr
depreci amort
incom expens
non- reconcili
tax effect adjust
sale
compani inform svb leerink llc
comput program system ticker
million excep per share data
sale suport
total cost sale
sale market
gener administr
non- reconcili
amort acquisition-rel intang
tax-effect rate adjust
benefit nol util
sale suport book
compani inform svb leerink llc
million except per share data
total revenu
sale market
research develop
gener administr
depreci amort
loss extinguish debt
non- reconcili
net incom common
accret redeem convert prefer stock
amort acquir intang
loss extinguish debt
adj net incom common
compani inform svb leerink llc
million except per share data
coordin benefit revenu
direct project oper expens
amort acquisit relat asset
total servic
non- reconcili
amort acquisit relat asset
compani inform svb leerink llc
million except per share data
revenu
sale market
technolog develop
gener administr
amort acquisition-rel intang
non- reconcili
stock base comp net tax rate
compani inform svb leerink llc
million excep per share data
servic
sale market
research developo
gener administr
depreci amort
non- reconcili
amort acquir intang asset
amort debt issuanc cost debt discount
tax equiti exercis
tax-effect rate adjust
tax equiti exercis
compani inform svb leerink llc
million except per share data
revenu
research develop
sale market
gener administr
chang fair valu conting consider
incom loss incom tax provis
net incom loss attribut common sharehold
dilut basic weight averag share
compani inform svb leerink llc
million except per share data
gaap revenu
amort intang acquisit relat asset
non-cash amort cash convert note
amort discount debt issuanc cost
non- reconcili
non-recur transact
non-cash charg interest expens
incom tax effect adj
compani inform svb leerink llc
million except per share data
softwar hardwar non-recur
revenu
sell gener administr
research develop cost net
amort acquir intang asset
total expens
earn incom tax
non- reconcili
amort acquir intang asset
amort defer debt issuanc cost
incom tax effect adj
compani inform svb leerink llc
million except per share data
subscript servic revenu
gaap revenu ex
adj revenu ex
adj gener administr
adj sale market
adj research develop
total incom expens
net incom common
chang fair valu warrant liabil
provid client averag period
compani inform svb leerink llc
million except per share data
total revenu
amort intang asset
non- reconcili
amort intang asset
compani inform svb leerink llc
million except per share data
servic
non- reconcili
collect fee
compani inform svb leerink llc
million excep per share data
revenu
advertis market
technolog develop
legal regulatori
gener administr
acquisit integr
depreci amortizaion
amort warrant
non- reconcili
amort warrant
acquisit integr
compani inform svb leerink llc
million excep per share data
total cost revenu
research develop
sale market
gener administr
depreci amort
chang fv acquisition-rel consider
non- reconcili
payrol tax expens relat stock option excercis
chang fv acquisition-rel consider
payrol tax expens relat stock option excercis
chang fv acquisition-rel consider
compani inform svb leerink llc
million except per share data
revenu
sale market
gener administr
non- reconcili
compani inform svb leerink llc
million except per share data
profession servic
total revenu
sale market
non- reconcili
amort purchas intang
compani inform svb leerink llc
